Works matching DE "DARATUMUMAB"

Results: 333
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma.

    Published in:
    Oncologist, 2020, v. 25, n. 12, p. 1067, doi. 10.1002/onco.13554
    By:
    • Michaleas, Sotirios;
    • Penninga, Elisabeth;
    • Hovgaard, Doris;
    • Dalseg, Anne‐Marie;
    • Rosso, Aldana;
    • Sarac, Sinan B.;
    • Jimenez, Jorge Camarero;
    • Fernández, Lucia López‐Anglada;
    • Fernández, Carolina Prieto;
    • Mangas‐SanJuan, Victor;
    • Garcia, Isabel;
    • Payares‐Herrera, Concepcion;
    • Sancho‐López, Aranzazu;
    • Enzmann, Harald;
    • Castro Lopes Silva, Marcia Sofia Sanches;
    • Duarte, Sílvia;
    • Pignatti, Francesco
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Cardiac Amyloidosis Treatment.

    Published in:
    Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 2, p. 59, doi. 10.14797/mdcvj.1050
    By:
    • STERN, LILY K.;
    • PATEL, JIGNESH
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Paraproteinemia and neuropathy.

    Published in:
    Neurological Sciences, 2021, v. 42, n. 11, p. 4489, doi. 10.1007/s10072-021-05583-7
    By:
    • Koike, Haruki;
    • Katsuno, Masahisa
    Publication type:
    Article
    30
    31
    32
    33

    Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01088-6
    By:
    • Chari, Ajai;
    • Kaufman, Jonathan L.;
    • Laubach, Jacob;
    • Sborov, Douglas W.;
    • Reeves, Brandi;
    • Rodriguez, Cesar;
    • Silbermann, Rebecca;
    • Costa, Luciano J.;
    • Anderson Jr, Larry D.;
    • Nathwani, Nitya;
    • Shah, Nina;
    • Bumma, Naresh;
    • Holstein, Sarah A.;
    • Costello, Caitlin;
    • Jakubowiak, Andrzej;
    • Wildes, Tanya M.;
    • Orlowski, Robert Z.;
    • Shain, Kenneth H.;
    • Cowan, Andrew J.;
    • Pei, Huiling
    Publication type:
    Article
    34
    35

    Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00988-x
    By:
    • Kostopoulos, Ioannis V.;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Malandrakis, Panagiotis;
    • Migkou, Magdalini;
    • Angelis, Nikolaos;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Krevvata, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Kastritis, Efstathios
    Publication type:
    Article
    36

    Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
    By:
    • Charalampous, Charalampos;
    • Goel, Utkarsh;
    • Kapoor, Prashant;
    • Binder, Moritz;
    • Buadi, Francis K.;
    • Cook, Joselle;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonder, Amie L.;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Hayman, Suzanne R.;
    • Hobbs, Miriam A.;
    • Hwa, Yi L.;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi;
    • Warsame, Rahma;
    • Kyle, Robert A.
    Publication type:
    Article
    37
    38
    39

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Article
    40
    41

    Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00655-z
    By:
    • Al Saleh, Abdullah S.;
    • Ebraheem, Mohammad S.;
    • Sidiqi, M. Hasib;
    • Dispenzieri, Angela;
    • Muchtar, Eli;
    • Buadi, Francis K.;
    • Warsame, Rahma;
    • Lacy, Martha Q.;
    • Dingli, David;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis V.;
    • Hogan, William J.;
    • Hayman, Suzanne R.;
    • Kapoor, Prashant;
    • Kumar, Shaji K.;
    • Gertz, Morie A.
    Publication type:
    Article
    42

    Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.

    Published in:
    2022
    By:
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.;
    • Rodriguez, Cesar;
    • Jakubowiak, Andrzej;
    • Efebera, Yvonne;
    • Reeves, Brandi;
    • Wildes, Tanya;
    • Holstein, Sarah A.;
    • Anderson Jr, Larry D.;
    • Badros, Ashraf;
    • Shune, Leyla;
    • Chari, Ajai;
    • Pei, Huiling;
    • Cortoos, Annelore;
    • Patel, Sharmila;
    • Bartlett, J. Blake;
    • Vermeulen, Jessica;
    • Lin, Thomas S.;
    • Richardson, Paul G.;
    • Voorhees, Peter
    Publication type:
    Letter
    43

    The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00548-7
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Baudi, Francis;
    • Muchtar, Eli;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Lisa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.

    Published in:
    Cells (2073-4409), 2021, v. 10, n. 5, p. 967, doi. 10.3390/cells10050967
    By:
    • Motais, Benjamin;
    • Charvátová, Sandra;
    • Walek, Zuzana;
    • Hrdinka, Matouš;
    • Smolarczyk, Ryszard;
    • Cichoń, Tomasz;
    • Czapla, Justyna;
    • Giebel, Sebastian;
    • Šimíček, Michal;
    • Jelínek, Tomáš;
    • Ševčíková, Tereza;
    • Sobotka, Jiří;
    • Kořístek, Zdeněk;
    • Hájek, Roman;
    • Bagó, Juli R.;
    • Kalyuzhny, Alexander E.
    Publication type:
    Article
    50